This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Top Stock Picks Under $5 for 2011

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

3. Ariad Pharmaceuticals (ARIA - Get Report)

Company Profile: Ariad Pharmaceuticals develops cancer treatments by regulating cell signaling with small molecules.

Share Price: $4.57 (Dec. 17)

2010 Stock Performance: 100%

Analyst Consensus: Nine researchers say investors should buy shares of Ariad Pharmaceuticals. There is one analyst with a "hold" rating on Ariad. No firm has a "sell" rating on the stock.

Bullish Case: Brean Murray Carret analyst Ling Wing reiterated a "buy" rating on Ariad in a Dec. 6 research report, based on expectations of Phase III trial data for ridaforolimus, which is Ariad's drug candidate to treat patients with advanced sarcomas.

"Near term, we expect partner Merck (MRK) to report the final analysis from the Phase III trial of ridaforolimus in advanced sarcoma patients in early [first quarter of 2011]," Wang wrote. "Although we have reservations in the outcome of this trial, we view the risk/reward at current levels to be favorable, especially with Merck taking full financial responsibility of the program."
9 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VTG $0.03 34.33%
ARIA $7.03 0.00%
ACHN $8.25 0.00%
C $45.57 0.00%
SNV $30.60 0.00%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs